A monthly video conference series about how you and LLS are advancing blood cancer research in the quest for cures.
With hosts Drs. Lou DeGennaro, Gwen Nichols and Lee Greenberger
LLS IMPACT: Bringing Leading-Edge Care to Underserved Communities
Thursday, April 22 at 2:00 PM (ET)
Clinical trials validate new breakthrough therapies and provide hope for patients who need new treatment options. But many patients face complex barriers to participating in trials, especially those in underserved or rural communities. With the new LLS IMPACT Grant Program, LLS is partnering with academic medical centers to pioneer new strategies that expand patient access to clinical trials. In this special LLS Research Now, we welcome leaders of the first three LLS IMPACT Grant awards—Mayo Clinic Rochester (Upper Midwest), Vanderbilt University Medical Center (South) and Weill Cornell Medicine Meyer Cancer Center (NYC)—to share about the innovative infrastructures they have created to address the specific needs of the regions they serve.
Michael R. Savona, MD (Vanderbilt Medical Center) seeks to improve therapies for patients with myeloid disease. He has worked on approximately 50 early phase clinical trials, and has led several international trials. As a part of these efforts, Dr. Savona has written several multicenter investigator-initiated clinical trials for which he serves as the sponsor-investigator with the FDA, and he mentors junior faculty in developing clinical trials.
Grzegorz Nowakowski, MD (Mayo Clinic Rochester) has a robust clinical trials portfolio and is a recognized leader in regulatory management and design of clinical trials. His main area of research focus is identification of new therapeutic targets and biomarkers in lymphoma, selection of tumor based biomarkers and tumor biology, and development of clinical trials inclusive biomarkers and adaptive design.
John Leonard, MD (Weill Cornell Medicine) is an internationally-recognized lymphoma expert, and serves as associate dean for clinical research at Weill Cornell and director of the Joint Clinical Trials Office at Weill Cornell and New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Leonard was also named chair of the Lymphoma Committee for the prestigious Alliance for Clinical Trials in Oncology, a role in which he develops and shepherds Phase II and Phase III clinical trials funded by the National Cancer Institute at medical centers across the country.
An Update on The LLS Children’s Initiative
Thursday, May 27 at 1:00 PM (ET)
Through The LLS Children’s Initiative, LLS is leveraging its role in the oncology community as a patient-centered convener to forge a groundbreaking collaboration to bring the power of precision medicine to pediatric patients. We seek no less than to transform the standard of care for children. May 2021 marks the two-year anniversary of launching this ambitious global effort. Join LLS leaders and our special guest, a leading pediatric researcher and chair of the Target & Biomarker Subcommittee of the LLS PedAL Master Clinical Trial, for an update on the progress and an outlook for what we can expect to see when the PedAL trial opens to enrollment later this year.
Louis J. DeGennaro, PhD, LLS President & CEO
Gwen Nichols, MD, LLS Chief Medical Officer, Co-Chair of the LLS Children's Initiative
Lee Greenberger, PhD, LLS Chief Scientific Officer
Soheil Meshinchi, MD, PhD (Fred Hutchinson Cancer Research Center), Chair of the Target & Biomarker Subcommittee for the LLS Children’s Initiative PedAL Master Clinical Trial
March 2021: Risks and Responses: COVID-19 Vaccines and Blood Cancer Patients (video here)
January 2021: Recent Advances and New Opportunities in Blood Cancer Research and Treatment (video here)
November 2020: Blood Cancer Prevention & Survivorship (video here)
October 2020: LLS's Venture Philanthropy Model for Accelerating Promising Therapies (video here)
September 2020: The Remarkable Promise of Immunotherapy (video here)
August 2020: Research at the Intersection of COVID-19 and Blood Cancer (video here)
July 2020: A Panel Discussion on the Career Development Program (video here)